The biological role of galanin in normal and neuropathic states.
Kerr
B J
BJ
Neuroscience Research Centre, Guy's, King's and St Thomas' School of Biomedical Sciences, King's College London, UK. bradley.kerr@kcl.ac.uk
Wynick
D
D
Thompson
S W
SW
McMahon
S B
SB
D000818:Animals; D019771:Axotomy / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D019004:Galanin / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D018377:Neurotransmitter Agents / Q000145:classification / Q000378:metabolism; D009619:Nociceptors / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D010146:Pain / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D017288:Pain Threshold / Q000187:drug effects / Q000502:physiology; D010523:Peripheral Nervous System Diseases / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D020671:Posterior Horn Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D044088:Receptors, Galanin; D018013:Receptors, Neuropeptide / Q000187:drug effects / Q000235:genetics / Q000378:metabolism
D018377:Neurotransmitter Agents; D044088:Receptors, Galanin; D018013:Receptors, Neuropeptide; D019004:Galanin